迈向基于证据的胆管炎诊断方法
本文通过全面文献检索评估胆管炎诊断标准的研究现状,纳入23项观察性研究(10,252例患者)。传统Charcot标准和Ranson标准敏感性不足,东京标准因复杂性难以实施,且缺乏对照验证研究。作者提出BILE标准(胆道影像异常或近期干预、炎症指标异常、肝功能异常、排除胆囊炎和急性胰腺炎)用于识别高危患者,但需前瞻性研究验证。
要点
- 传统Charcot和Ranson标准诊断胆管炎敏感性不足
- 东京标准因复杂性限制实施,且缺乏对照验证研究
- BILE标准可识别胆管炎高危患者,但需前瞻性验证
核心结论
- 需要开展对照验证研究以建立符合当代临床价值且易于实施的胆管炎诊断标准。
- BILE标准简单易行,但需前瞻性研究评估其诊断效能及避免不必要ERCP的能力。
研究设计与样本
- 全面文献检索PubMed(1898年至今)、Web of Science(1900年至2019年7月15日)、Embase(1943年至2019年7月15日)和Cochrane图书馆(1898年至2019年7月15日)。
- 纳入23项观察性研究,共10,252例患者,评估单项和联合标准诊断胆管炎的性能。
主要发现
- 传统Charcot标准和Ranson标准诊断胆管炎敏感性不足。
- 东京标准因复杂性限制实施,且缺乏对照验证研究。
- 现有文献提示BILE标准可识别胆管炎高危患者:胆道影像异常或近期干预、炎症指标异常、肝功能异常、排除胆囊炎和急性胰腺炎。
关键数值与推荐
- BILE标准包含4项:Biliary imaging abnormalities or recent intervention(胆道影像异常或近期干预)、Inflammatory test abnormalities(炎症指标异常)、Liver test abnormalities(肝功能异常)、Exclusion of cholecystitis and acute pancreatitis(排除胆囊炎和急性胰腺炎)。
临床怎么用
- ERCP是胆管炎的有效治疗,但鉴于操作相关并发症,应仅用于诊断概率高的患者。
- BILE标准可用于识别胆管炎高危患者,但需前瞻性研究验证其诊断性能和避免不必要ERCP的能力。
局限性
- 缺乏对照验证胆管炎诊断标准的研究。
- BILE标准需前瞻性研究评估其诊断性能和避免不必要ERCP的能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Despite improvements in imaging and laboratory medicine, consensus criteria for the diagnosis of cholangitis are lacking. Although ERCP is an effective treatment for cholangitis, it should be reserved for those patients with a high probability of the diagnosis, given the morbidity associated with the procedure. METHODS: A comprehensive literature search of PubMed (from 1898 to present), Web of Science (1900 to July 15, 2019), Embase (1943 to July 15, 2019), and the Cochrane library (1898 to July 15, 2019) was performed to identify studies that reported on diagnostic paradigms and individual diagnostic parameters of cholangitis. This was used to identify domains associated with high probability of cholangitis. RESULTS: We identified 23 observational studies (10,252 patients) that evaluated the performance of individual and combined criteria for the diagnosis of cholangitis. Traditional paradigms including Charcot's criteria and Ranson's criteria have inadequate sensitivity, and complexity has limited the implementation of the contemporary Tokyo criteria. Furthermore, controlled studies to validate diagnostic criteria for cholangitis are lacking. Existing literature suggests that 4 criteria, summarized by the acronym BILE, identifies those at high risk of cholangitis: Biliary imaging abnormalities or recent intervention, Inflammatory test abnormalities, Liver test abnormalities, and Exclusion of cholecystitis and acute pancreatitis. CONCLUSIONS: There is a need for cholangitis diagnostic criteria that are supported by controlled validation studies, consistent with contemporary clinical values, and amenable to implementation. The BILE criteria are straightforward but require prospective study of their diagnostic performance and ability to avert unnecessary ERCP.
引用
- Buxbaum J, Qumseya B, Wani S, et al. Toward an evidence-based approach for cholangitis diagnosis. Gastrointest Endosc. 2021. PMID: 33905719. doi:10.1016/j.gie.2021.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。